Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Dash Bio announced it raised $30 Million in an initial filing from an offering of $30 Million
Amount Raised
$30 Million
Round Type
Venture - Series Unknown
BostonBiotechnologyInvestors
Description
Dash Bio has raised $30 million in Series A financing to enhance infrastructure for next-generation medicine development. The round was led by Oak HC/FT, with participation from existing investors Freestyle Capital and Swift Ventures. This funding aims to streamline drug development processes that are often resource-intensive. Dash Bio is focused on modernizing the support infrastructure for drug development.
Related People
Funding Insights
Based on industry dataWatching Dash Bio? See every signal — funding, hires, M&A, contracts, sentiment.
Book a demoChoose your plan